NIAGEN BIOSCIENCE INC (NAGE) Stock Cash Flow
NASDAQ:NAGE - Nasdaq - US1710774076 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 14.11M | 8.55M | -4.94M | -16.54M | -27.13M | |||
| Depreciation Amortization | 793.00K | 814.00K | 1.03M | 1.06M | 1.12M | |||
| Change In Working Capital | 6.46M | 3.13M | 4.56M | -6.32M | -5.01M | |||
| Interest Paid | N/A | 1.00K | 2.00K | 0.00 | 0.00 | |||
| Other non cash items | -1.66M | -389.00K | 6.46M | 6.71M | 6.86M | |||
| OPERATING CASH FLOW | 19.70M | 12.11M | 7.12M | -15.10M | -24.16M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -154.00K | -163.00K | -148.00K | -330.00K | -410.00K | |||
| Other Investing Activity | N/A | 20.00K | 5.00K | N/A | 0.00 | |||
| INVESTING CASH FLOW | -134.00K | -143.00K | -143.00K | -330.00K | -410.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -11.00K | -11.00K | -15.00K | -20.00K | -30.00K | |||
| Stock Issued/Repurchased | N/A | 5.43M | 0.00 | 7.75M | 36.24M | |||
| Other Financing Activity | -47.00K | -52.00K | -75.00K | -80.00K | -110.00K | |||
| FINANCING CASH FLOW | 8.49M | 5.37M | -90.00K | 7.65M | 36.09M | |||
| CHANGE IN CASH | 28.05M | 17.34M | 6.88M | -7.78M | 11.52M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 19.70M | 12.11M | 7.12M | -15.10M | -24.16M | |||
| Capital Expenditure | -154.00K | -163.00K | -148.00K | -330.00K | -410.00K | |||
| FREE CASH FLOW | 19.54M | 11.95M | 6.97M | -15.43M | -24.57M | |||
All data in USD